Meet Resilience, a brand new startup that desires to assist most cancers therapy institutes in addition to most cancers sufferers at each step of the therapy journey. It’s an formidable mission based by two well-known French entrepreneurs. They wish to leverage their tech expertise for this new healthcare startup.
Behind the scenes, there are two co-CEOs — Céline Lazorthes and Jonathan Benhamou. Nicolas Helleringer and Matthieu Pozza are the 2 remaining co-founders appearing as CTO and CPO respectively. Lazorthes beforehand co-founded Leetchi, the main cash pot firm in France. She additionally began MangoPay, a market fee resolution, as a spinout firm. Crédit Mutuel Arkéa acquired each corporations.
Benhamou co-founded PeopleDoc, a cloud-based HR service. In 2018, his firm was acquired by Final Software program. Following the acquisition, he served as an govt within the publicly quoted firm. Shortly after, non-public fairness agency Hellman & Friedman Capital Companions acquired Final Software program.
Final 12 months, they each spent a number of time working collectively on a nonprofit referred to as ProtegeTonSoignant. Together with 140 folks, they raised €7.4 million ($8.8 million) in donations to purchase private protecting gear and ship it to hospitals in want. It was a fundraising and logistics problem.
After spending a number of time speaking with healthcare professionals, they determined to “dedicate not less than the subsequent ten years to those that save lives,” Lazorthes stated.
It looks as if an formidable guess, and so they’re conscious of that. “We don’t know something about healthcare similar to we didn’t know something about HR and finance. We’re getting into a market that’s extremely regulated,” Benhamou instructed me.
That’s why they selected to deal with one space particularly — most cancers care. Whereas analysis institutes have made some great progress over the previous few years, it has grow to be more and more extra sophisticated to deal with most cancers. As an example, Benhamou says he expects to see 300 new therapies over the subsequent three years. Remedy is slowly evolving from broad spectrum therapies to focused therapies.
Most cancers therapy amenities face three points. First, “a human mind can’t assimilate all this knowledge,” Benhamou stated. Second, as life expectancy will increase, there are extra most cancers circumstances yearly. A tumor board goes to spend a minute and a half or two minutes on a particular case to make a therapeutic resolution.
Third, on account of the primary two issues, sufferers are left on their very own. As an example, they undergo from unwanted side effects as a result of there’s no dosage adjustment of their therapy.
Ranging from there, Resilience desires to grow to be a full-stack software program resolution for most cancers therapy for each the medical group and sufferers. In terms of practitioners, Resilience shall be a software-as-a-service resolution that may increase therapeutic choices. The corporate will categorize scientific literature, use machine studying to search out some similarities with previous circumstances and floor medical trials based mostly on varied standards.
In terms of sufferers, there shall be an internet and cellular app to entry content material and details about their most cancers. Specifically, Resilience might enable you perceive unwanted side effects and deal with them.
“Our purpose is to show that the app can enhance the standard of lifetime of the sufferers,” Lazorthes stated. Resilience additionally desires to leverage its app to ask questions and accumulate knowledge to enhance therapies.
The startup is already placing collectively a knowledge science group. It should use pure language processing to parse scientific literature. It should additionally work with a medical group to double-check all the things.
In terms of discovering similarities between sufferers, the corporate is signing partnerships with varied hospitals to get knowledge from previous circumstances.
Resilience has raised a $6 million funding spherical (€5 million) led by Singular, the VC agency based by former Alven companions Raffi Kamber and Jérémy Uzan. Tech enterprise angels Nathalie Balla (La Redoute), Xavier Niel (Free), Jean-Charles Samuelian (Alan), Roxanne Varza (Station F) and extra are additionally collaborating.
There are additionally some healthcare traders in as we speak’s funding spherical, corresponding to Charles Ferté (AstraZeneca), Philippe Dabi (Bioclinic) and Thomas Clozel (Owkin).
Resilience is a mission-driven firm — the corporate is partnering with a scientific board and a affected person board. Gustave Roussy, one of many main most cancers analysis institutes on the earth, can be appearing as a co-founder in Resilience.
That’s a number of stakeholders, nevertheless it’s the best factor to do whenever you’re constructing a healthcare firm. Resilience now has the best system of checks and steadiness to iterate on its product and roll out a product that has an opportunity of really bettering most cancers therapy.